1. Home
  2. About
  3. Newsroom
  4. Medicine’s Leila Hojat, a principal investigator of clinical trials of remdesivir as potential COVID-19 treatment spoke about the drug, expectations and balancing the need to stay realistic

Medicine’s Leila Hojat, a principal investigator of clinical trials of remdesivir as potential COVID-19 treatment, spoke about the drug, expectations and balancing the need to stay realistic